Date: 2025/04/02 - 23:32
The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Here, two people who've relied on compounded GLP-1 drugs share their stories.
Date: 2025/04/02 - 23:00
The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Here, two people who've relied on compounded GLP-1 drugs share their stories.
Date: 2025/04/01 - 18:00
A new Norwegian study finds that one hour of screen time at bedtime results in a 59% higher risk of insomnia and 24 fewer minutes of sleep. The findings indicate that social media use is no more disruptive to sleep than watching TV or movies or reading on a mobile device.
Date: 2025/03/12 - 01:00
HHS Secretary Robert F. Kennedy Jr. recommends alternative treatment and prevention methods for measles amid growing outbreaks in 11 states and New York City. Kennedy has linked poor diet and health to measles and touts vitamin A and cod liver oil as treatments.
Date: 2025/02/13 - 22:00
Robert F. Kennedy Jr. is expected to shake up the U.S. healthcare industry after being confirmed by the Senate as the new secretary for Health and Human Services (HHS). Kennedy's "Make America Healthy Again" plan aims to help reduce the growing chronic disease burden in the U.S.
Date: 2025/01/24 - 02:32
The Trump administration ordered an immediate pause on public communications from federal health agencies like the CDC, FDA, and NIH. The U.S. Department of Health and Human Services (HHS) says it expects the pause to be temporary.
Date: 2025/01/22 - 02:00
President Trump began his first day in office by signing a series of executive orders reversing many Biden-era policies. Among them, Trump announced the U.S. would withdraw from the WHO, cutting off funding for important global health initiatives.
Date: 2025/01/22 - 00:32
A large study published in Nature Medicine reviewed the effects of GLP-1 drugs like Ozempic and Mounjaro on 175 different health outcomes. The findings show benefits for brain and heart health, but risks of developing gastrointestinal, kidney, and pancreatic issues.